Loading...
NKT cell adjuvants in therapeutic vaccines against hematological cancers
Immune adjuvants aimed at initiating or re-activating host immunity against poorly immunogenic cancers represent a potential tool for immunotherapy. By employing the natural killer T (NKT) cell agonist α-galactosylceramide in a whole tumor cell therapeutic vaccine approach, we have achieved potent s...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Landes Bioscience
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3583928/ https://ncbi.nlm.nih.gov/pubmed/23482240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22615 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|